09
Feb
Andrew Kathindi The Ministry of Health and Social Services (MOHSS) is scrambling for answers after it emerged that the AstraZeneca vaccine, the same vaccine Namibia is expected to receive through the COVAX facility, is not as effective against the new variant of COVID-19. MOHSS Executive Director, Ben Nangombe, told Windhoek Observer that the ministry’s technical team is meeting urgently. AstraZeneca is manufactured by a British–Swedish pharmaceutical company. "My technical team is discussing the matter right now in the context of those developments. We will then issue a position and the way forward, based on the available information. We are dealing…